Glaucoma surgery with CLASS

Article

Carbon dioxide laser assisted sclerectomy surgery (CLASS) is being used as an effective and safe, minimally invasive treatment for glaucoma. In this article, two surgeons at the forefront of research, development and implementation of this approach discuss this surgical option and its benefits for the ophthalmic market.

"We resort to traditional penetrating surgical methods such as trabeculectomy and tube shunts when the state of the disease is dire enough to exceed the high risks associated with these treatments," explained Prof. Assia.

Related Videos
Dr Nir Shoham Hazon, Director, Miramichi EyeNB Centre of Excellence, New Brunswick, Canada
Paul Harasymowycz, MD
Ms Neeru Vallabh on a virtual call with Ophthalmology Times Europe
Fritz Hengerer, MD, PhD, Director, Eye Hospital at Bürgerhospital, Frankfurt, Germany
Dr Sheng Lim, professor of glaucoma studies at St Thomas' Hospital, London
Kasperi Kankare at the iCare booth at ESCRS
Related Content
An illustration made with AI shows a man with digital imagery overlaid over his head. Image credit: ©fotogurmespb – stock.adobe.com

How amyloid-beta peptide and tau protein demonstrate degeneration

March 21st 2024
Article

Proteins common to Alzheimer disease play a significant role in glaucoma

A person with wrinkles looks directly at the camera. They have blue eyes. Image credit: ©yana136 – stock.adobe.com

Promising avenues could simplify glaucoma management – just in time

February 23rd 2024
Article

Innovative therapies scale up to meet needs of a growing patient population

The skyline of Frankfurt at night. Image credit: ©Anselm – stock.adobe.com

Sight Sciences announces European launch of OMNI Surgical System Ergo-Series

February 15th 2024
Article

The company made its CE Mark announcement during the ESCRS Winter Meeting

The European Patent Office headquarters in Munich, Germany. Image credit: ©nmann77 – stock.adobe.com

Iridex Corporation receives European patent on MicroPulse technology

February 6th 2024
Article

According to the company, the patent further protects Iridex’s intellectual property encompassing laser systems in ophthalmology and related fields

An elderly man holds a magnifying glass close to his eye. Image credit: ©Irina – stock.adobe.com

What do you do when there is no cataract?

January 30th 2024
Article

Standalone, minimally-invasive glaucoma treatments

A photo of London at sunset. Image credit: ©IRStone – stock.adobe.com

Iridex and Imperial College Healthcare NHS Trust announce collaborative MicroPulse TLT study

January 24th 2024
Article

The partnership establishes a large-scale enrollment platform for research on MicroPulseTransscleral Laser Therapy (TLT)

© 2024 MJH Life Sciences

All rights reserved.